Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE2 | O96020 | 12/20 | 0.84 |
| ▸ | CCNE1 | P24864 | 12/20 | 0.84 |
| ▸ | CDK2 | P24941 | 12/20 | 0.84 |
| ▸ | CDK1 | P06493 | 5/20 | 0.84 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.84 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.84 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.84 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.84 |
| ▸ | PDE5A | O76074 | 1/20 | 0.84 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.84 |
| ▸ | CDK7 | P50613 | 1/20 | 0.84 |
| ▸ | CDK9 | P50750 | 1/20 | 0.84 |
| ▸ | CCNH | P51946 | 1/20 | 0.84 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.84 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.84 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.61 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1394958 | 0.91 | CCNE2 (1.00) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL1394954 | 0.86 | CCNE1 (0.77) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL3686041 | 0.86 | CCNE2 (0.77) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL7702451 | 0.85 | CDK2 (0.64) | CCNE2CCNE1CDK2CDK1CDK5 | |
| Myoseverin SCHEMBL13325947 | 0.82 | TDP1 (1.00) | CCNE2CCNE1CDK2CDK1CDK5 | |
| Myoseverin SCHEMBL29376276 | 0.82 | TDP1 (1.00) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL14071580 | 0.81 | CDK2 (0.85) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL5466712 | 0.81 | CCNE1 (0.70) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL1443236 | 0.80 | TDP1 (0.80) | CCNE2CCNE1CDK2CDK1CDK5 | |
| SCHEMBL6143053 | 0.80 | CDK2 (1.00) | CCNE2CCNE1CDK2CDK1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325931-A1 | USE OF CDK INHIBITORS FOR THE TREATMENT OF GRANULOCYTE MEDIATED DISORDERS | UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2009-12-31 | — | — | US | disclosed |
| EP-2061446-A2 | USE OF CDK INHIBITORS FOR THE TREATMENT OF GRANULOCYTE MEDIATED DISORDERS | University Court of the University of Edinburgh (GB) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008012563-A2 | USE OF CDK INHIBITORS FOR THE TREATMENT OF GRANULOCYTE MEDIATED DISORDERS | UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2008-01-31 | — | — | WO | disclosed |